The "super mutant" of yeast FMN adenylyltransferase enhances the enzyme turnover rate by attenuating product inhibition

Carlos Huerta, Nick V. Grishin, Hong Zhang

Research output: Contribution to journalArticle

2 Scopus citations


FMN adenylyltransferase (FMNAT) is an essential enzyme catalyzing the last step of a two-step pathway converting riboflavin (vitamin B2) to FAD, the ubiquitous flavocoenzyme. A structure-based mutagenesis and steady-state kinetic analysis of yeast FMNAT unexpectedly revealed that mutant D181A had a much faster turnover rate than the wild-type enzyme. Product inhibition analysis showed that wild-type FMNAT is strongly inhibited by FAD, whereas the D181A mutant has an attenuated product inhibition. These results provide a structural basis for the product inhibition of the enzyme and suggest that product release may be the rate-limiting step of the reaction.

Original languageEnglish (US)
Pages (from-to)3615-3617
Number of pages3
Issue number21
StatePublished - May 28 2013


ASJC Scopus subject areas

  • Biochemistry

Cite this